Bloomberg Originals
@business·5.1M subscribers·49.5K videos
Ackman: Plan to Discuss Drug Prices With Valeant Board
Posted
April 27, 2016
Views
14,319
Likes
90
Comments
13
Engagement
0.72%
April 27, 2016
14,319
90
13
0.72%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
2:10Now PlayingApril 27 -- Bill Ackman, Pershing Square Capital Management's chief executive officer, speaks at a Senate hearing on Valeant and drug pricing. Pershing Square has investments in Valeant.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
